Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × Temozolomide × Clear all

Phase

Status

Completed 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 40 Glioma 14 Neuroblastoma 13 Brain Neoplasms 12 Astrocytoma 9 Rhabdomyosarcoma 8 Sarcoma, Ewing 7 Neoplasms 7 Recurrence 6 Oligodendroglioma 5 Medulloblastoma 5 Sarcoma 4 Osteosarcoma 4 Melanoma 4 Small Cell Lung Carcinoma 3 Lymphoma 3 Gliosarcoma 3 Diffuse Intrinsic Pontine Glioma 3 Wilms Tumor 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Neuroectodermal Tumors, Primitive 2 Neoplasm Metastasis 2 Hepatoblastoma 2 Fallopian Tube Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Spinal Cord Neoplasms 1 Solid Tumor 1 Rhabdoid Tumor 1

Interventions

cabozantinib 7 pembrolizumab 5 Nivolumab 5 Radiosurgery 3 Ipilimumab 3 Blood Specimen Collection 3 Axitinib 3 lenvatinib 2 Radiotherapy 2 Biopsy 2 zimberelimab 1 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 olaparib 1 gallium Ga 68 dotatate 1 brodalumab 1 belzutifan 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Ultrasonography 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Radionuclide Imaging 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡